Cartesian Therapeutics
RNAC
#6809
Rank
S$0.65 B
Marketcap
$25.76
Share price
-1.30%
Change (1 day)
-9.24%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.43

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.43. In 2021 the company made an earnings per share (EPS) of -$0.33 an increase over its 2020 EPS that were of -$0.93.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.43
2021-$0.33-65.22%
2020-$0.93-43.44%
2019-$1.65-58.08%
2018-$3.94-9.35%
2017-$4.35-29.16%
2016-$6.14